Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 2 years ago

Possible Interaction: Neuropeptide Y and Potassium

supplement:

Potassium

Research Papers that Mention the Interaction

NPY significantly inhibited ACh release stimulated by potassium (55 mM); by adenylate cyclase agonists forskolin (10(-6) M) and cholera toxin (10(-8) M); and by calcitonin gene-related peptide, cholecystokinin octapeptide, and vasoactive intestinal peptide (each 10(-8) M).
The Journal of surgical research  •  1991  |  View Paper
In contrast, NPY (10−6 M) produced significant inhibition of amylase release from pancreatic lobules that had been stimulated by 75 μM potassium (135 ± 11% versus 177 ± 18% of basal level) or by 25 μM veratridine (196 ± 19% versus 398 ± 152%).
Pancreas  •  1991  |  View Paper
NPY was also seen to decrease the potassium‐induced release of norepinephrine (NE) from slices obtained from the posterior hypothalamic nucleus.
Synapse  •  1988  |  View Paper
Addition of potassium (45 mM) resulted in a 3-fold increase in the rate of NPY release in a calcium dependent fashion.
Neuropharmacology  •  1985  |  View Paper